Reduction of salivary flow with Scopoderm TTS.
Scopoderm transdermal therapeutic system (TTS) is a form of application permitting programmed release of scopolamine through the skin into the bloodstream. Scopoderm TTS is indicated for prevention of nausea and vomiting associated with motion sickness. The most common side effect associated with its use is dryness of the mouth. We have been using Scopoderm TTS for reducing salivary flow in patients with sialorrhea or with difficulties in swallowing normal amounts of salivary secretions. Good results were achieved with minimal discomfort from adverse effects. We recommend the use of Scopoderm TTS in selected cases of sialorrhea and drooling, preoperatively and postoperatively in patients undergoing surgery of oral, laryngeal, and pharyngeal lesions.
Talmi
Y P
YP
Department of Otolaryngology, Golda Medical Center, Hasharon Hospital, Petah-Tiqva, Israel.
Finkelstein
Y
Y
Zohar
Y
Y
Laurian
N
N
D000279:Administration, Cutaneous; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006258:Head and Neck Neoplasms / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care; D012472:Salivation / Q000187:drug effects*; D012601:Scopolamine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D012798:Sialorrhea / Q000188:drug therapy
D012601:Scopolamine